» Articles » PMID: 18382686

Toll-like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis

Overview
Journal PLoS One
Date 2008 Apr 3
PMID 18382686
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, heightened systemic translocation of microbial products was found in persons with chronic HIV infection and this was linked to immune activation and CD4(+) T cell homeostasis.

Methodology: We examined here the effects of microbial Toll-like receptor (TLR) ligands on T cell activation in vitro.

Conclusions/findings: We show that exposure to TLR ligands results in activation of memory and effector CD4(+) and CD8(+) T cells. After exposure to each of 8 different ligands that activate TLRs 2, 3, 4, 5, 7, 8, and 9, CD8(+) T cells are activated and gain expression of the C type lectin CD69 that may promote their retention in lymphoid tissues. In contrast, CD4(+) T cells rarely increase CD69 expression but instead enter cell cycle. Despite activation and cell cycle entry, CD4(+) T cells divide poorly and instead, disproportionately undergo activation-induced cell death. Systemic exposure to TLR agonists may therefore increase immune activation, effector cell sequestration in lymphoid tissues and T cell turnover. These events may contribute to the pathogenesis of immune dysfunction and CD4+ T cell losses in chronic infection with the human immunodeficiency virus.

Citing Articles

Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4 T Cells.

Znaidia M, de Souza-Angelo Y, Letoffe S, Staropoli I, Grzelak L, Ghigo J Microbiol Spectr. 2023; 11(2):e0431322.

PMID: 36853052 PMC: 10100953. DOI: 10.1128/spectrum.04313-22.


Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort.

Hernandez J, Tamargo J, Martinez S, Martin H, Campa A, Sekaly R PLoS One. 2022; 17(10):e0275675.

PMID: 36215260 PMC: 9550062. DOI: 10.1371/journal.pone.0275675.


Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.

Luo Z, Health S, Li M, Yang H, Wu Y, Collins M EBioMedicine. 2022; 80:104037.

PMID: 35500539 PMC: 9065923. DOI: 10.1016/j.ebiom.2022.104037.


The 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients.

Jablonska A, Jablonowska E, Studzinska M, Kamerys J, Paradowska E Cells. 2021; 10(9).

PMID: 34572011 PMC: 8470824. DOI: 10.3390/cells10092360.


[rCsHscB derived from has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice].

Hua H, Dong X, Zhang Y, Fang F, Zhang B, Li X Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(5):664-670.

PMID: 34134952 PMC: 8214966. DOI: 10.12122/j.issn.1673-4254.2021.05.05.


References
1.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

2.
Abrams D, Lewis B, Beckstead J, Casavant C, Drew W . Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome?. Ann Intern Med. 1984; 100(6):801-8. DOI: 10.7326/0003-4819-100-6-801. View

3.
Crellin N, Garcia R, Hadisfar O, Allan S, Steiner T, Levings M . Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol. 2005; 175(12):8051-9. DOI: 10.4049/jimmunol.175.12.8051. View

4.
Sancho D, Gomez M, Sanchez-Madrid F . CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005; 26(3):136-40. DOI: 10.1016/j.it.2004.12.006. View

5.
Andersson J, Fehniger T, Patterson B, Pottage J, Agnoli M, Jones P . Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 1998; 12(11):F123-9. DOI: 10.1097/00002030-199811000-00004. View